Skip to main content

Want a detailed portfolio tracker?

Eyenovia (HYPD) P/E (2018 - 2026)

Eyenovia (HYPD) P/E from Apr 2, 2018 to Jun 3, 2026. The TTM Eyenovia (HYPD) P/E is -0.77. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Eyenovia (HYPD)

YearP/EChange
2026-0.77+44.87%
2025-0.53+150.32%
2024-0.21-93.32%
2023-3.19+7.21%
2022-2.98-62.43%
2021-7.92+17.73%
2020-6.73+127.34%
2019-2.96+70.73%
2018-1.73N/A

Comparison Eyenovia (HYPD) P/E with competitors

Eyenovia (HYPD) P/E is -0.77.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.22%
NBYStablecoin Development Corp0.10-113.23%
ENLVEnlivex Therapeutics Ltd0.15-119.44%
FGENFibroGen Inc0.24-131.07%
TRAWTraws Pharma Inc0.47-161.20%
FBIOFortress Biotech Inc0.71-191.38%
CHRSCoherus Biosciences Inc0.98-226.60%
ORMPOramed Pharmaceuticals Inc1.47-290.71%
AGENAgenus Inc2.05-365.14%
VIVSVivoSim Labs Inc2.54-428.21%
INVAInnoviva Inc3.19-512.69%
CRMDCorMedix Inc3.65-571.87%
ABEOAbeona Therapeutics Inc4.20-644.26%
VXRTVaxart Inc4.26-651.59%
CVACCureVac N.V.4.45-675.41%
SRPTSarepta Therapeutics Inc4.62-698.52%
GLPGGalapagos NV4.86-728.89%
RIGLRigel Pharmaceuticals4.92-736.75%
ZVRAZevra Therapeutics Inc4.97-743.80%
ABUSArbutus Biopharma Corp5.69-836.95%
CGENCompugen Ltd7.38-1055.73%
AUPHAurinia Pharmaceuticals Inc9.25-1297.45%
ACADAcadia Pharmaceuticals Inc9.59-1341.02%
OMEROmeros Corporation9.88-1379.25%
PLXProtalix BioTherapeutics Inc9.91-1382.58%
SPROSpero Therapeutics Inc10.73-1489.44%
ADMAAdma Biologics Inc11.33-1566.57%
SVASinovac Biotech Ltd11.44-1580.21%
TBPHTheravance Biopharma Inc11.78-1624.30%
HRMYHarmony Biosciences Holdings Inc12.18-1676.56%
TGTXTG Therapeutics Inc13.18-1805.87%
INCYIncyte Corp13.38-1832.09%
SABSSAB Biotherapeutics Inc14.06-1919.55%
XOMAXOMA Corp14.95-2034.43%
REGNRegeneron Pharmaceuticals Inc14.98-2038.96%
PBYIPuma Biotechnology Inc15.05-2048.04%
EXELExelixis Inc15.79-2144.40%
NAGENiagen Bioscience Inc16.35-2216.89%
CPRXCatalyst Pharmaceuticals Inc17.34-2345.01%
MDXGMimedx Group Inc17.38-2348.97%
ARGXArgen X SE23.07-3086.26%
HALOHalozyme Therapeutics Inc23.20-3102.96%
XOMAOXOMA Corp25.34-3380.49%
VRTXVertex Pharmaceuticals Inc25.66-3420.75%
XOMAPXOMA Corp25.67-3422.60%
CTMXCytomX Therapeutics Inc25.70-3426.20%
ASNDAscendis Pharma A/S26.35-3511.13%
RPRXRoyalty Pharma plc - Class A27.50-3658.86%
SLNOSoleno Therapeutics Inc29.02-3855.59%
LGNDLigand Pharmaceuticals Inc - Class B30.19-4007.18%
BMRNBiomarin Pharmaceutical Inc37.51-4954.74%
APLSApellis Pharmaceuticals Inc39.02-5150.69%
KRYSKrystal Biotech Inc39.70-5238.24%
GMABGenmab40.20-5303.74%
ONCBeiGene Ltd67.03-8775.62%
TECHBio-Techne Corp68.59-8978.58%
VCELVericel Corp80.63-10536.23%
PHARPharming Group N.V.87.74-11456.63%
ALNYAlnylam Pharmaceuticals Inc124.93-16270.77%
TLXTelix Pharmaceuticals Ltd139.89-18206.72%
CORTCorcept Therapeutics Inc158.39-20601.09%